1599-5453 Contact Us KO
Diagnostic Tools

Autonomic Function Test Battery

Autonomic Function Test Battery · Z01.89

The autonomic function test battery is a standardized testing protocol that comprehensively evaluates sympathetic and parasympathetic function through multiple standardized tests, overcoming the limitations of individual tests and quantitatively assessing the extent and severity of autonomic dysfunction.

2026-03-28

At a Glance

The autonomic function test battery is a standardized combination of tests including heart rate variability testing (deep breathing variability, Valsalva ratio, 30:15 ratio), tilt table test, Valsalva maneuver test, and QSART (quantitative sudomotor axon reflex test). It follows the Mayo Clinic protocol and American Academy of Neurology standards, with results integrated to separately assess sympathetic adrenergic, sympathetic cholinergic (sudomotor), and parasympathetic function. It is used for detailed evaluation of all patients with suspected autonomic dysfunction.

Definition and Overview

The autonomic function test battery is a diagnostic protocol that systematically evaluates sympathetic and parasympathetic function through multiple standardized tests [2]. Because the complex functions of the autonomic nervous system cannot be adequately assessed by a single test, complementary tests are combined for comprehensive evaluation.

The autonomic reflex screen (ARS) developed by Low et al. at Mayo Clinic is the most widely used standard protocol [1]. This protocol includes deep breathing test with heart rate variability, Valsalva maneuver test, tilt table test (or active standing test), and QSART.

Component Tests

Heart Rate Variability Tests (Parasympathetic Assessment)

The deep breathing test measures heart rate fluctuation (E:I ratio) during 6 deep breaths per minute. The difference between maximum and minimum heart rate during breathing is the normal response; a diminished difference suggests parasympathetic (vagal) dysfunction [4].

The Valsalva ratio is the maximum heart rate during the Valsalva maneuver divided by the minimum heart rate after the maneuver, serving as an indicator of parasympathetic function. Values below the age-adjusted lower limit of normal are considered abnormal [4].

The 30:15 ratio is the R-R interval ratio of the 15th and 30th heartbeats after standing. It evaluates the reflex response of heart rate increase (15th beat) followed by decrease (30th beat) immediately after standing, reflecting parasympathetic function.

Blood Pressure Response Tests (Sympathetic Adrenergic Assessment)

Blood pressure responses during the Valsalva maneuver assess sympathetic adrenergic function. Late phase II (IIb) blood pressure recovery and phase IV blood pressure overshoot are normal responses; loss of this pattern indicates sympathetic dysfunction [1].

The tilt table test or active standing test measures blood pressure changes over 3 minutes after standing. A drop in systolic blood pressure of 20 mmHg or more, or diastolic blood pressure of 10 mmHg or more, upon standing is diagnostic of orthostatic hypotension.

QSART (Sympathetic Cholinergic/Sudomotor Assessment)

The quantitative sudomotor axon reflex test (QSART) quantifies sweat output by stimulating eccrine sweat gland axon reflexes via acetylcholine iontophoresis [3]. Measurements are taken at four sites -- forearm (proximal), proximal leg, ankle, and dorsal foot -- to assess the distal-to-proximal functional distribution of sympathetic cholinergic fibers.

CASS (Composite Autonomic Scoring Scale)

The composite autonomic scoring scale (CASS) quantifies battery test results on a 0-to-10 scale, representing the severity of autonomic dysfunction as a single composite score [1].

CASS comprises three subscores: cardiovagal score (0-3 points) based on deep breathing test, Valsalva ratio, and 30:15 ratio; adrenergic score (0-4 points) based on orthostatic blood pressure response and Valsalva blood pressure response; and sudomotor score (0-3 points) based on QSART.

A CASS of 0 is normal, 1-3 indicates mild, 4-6 moderate, and 7-10 severe autonomic dysfunction [1]. CASS is valuable for longitudinal tracking of autonomic dysfunction and monitoring treatment response.

Pre-Test Preparation

Standardized preparation is required for accurate test results [2]. Caffeine beverages (coffee, tea, energy drinks) and alcohol should be avoided starting the day before testing. Fasting for at least 3 to 4 hours on the test day is recommended. Medications affecting the cardiovascular system (beta-blockers, alpha-blockers, anticholinergics, tricyclic antidepressants) should be discussed with the attending physician regarding temporary discontinuation. Smoking is prohibited on the test day. The patient should rest in the supine position for at least 30 minutes before testing.

Clinical Applications

Diabetic autonomic neuropathy: used for diagnosis and severity assessment of cardiac autonomic neuropathy, incorporating the 5 tests recommended by the ADA [4]. POTS and orthostatic hypotension: orthostatic blood pressure and heart rate responses enable accurate subtype classification and mechanism evaluation. MSA vs. Parkinson's disease differentiation: the pattern and extent of autonomic involvement aids in distinguishing these conditions. Small fiber neuropathy: QSART detects early damage [3]. It is also used for evaluating autoimmune autonomic ganglionopathy.

Frequently Asked Questions

The autonomic nervous system consists of the sympathetic and parasympathetic divisions, each responsible for different functions. Since no single test can assess all aspects, a combination of multiple standardized tests is performed -- this is called an autonomic function test battery. It includes heart rate variability testing, tilt table test, Valsalva maneuver test, and sudomotor function testing, with integrated analysis to determine the location, extent, and severity of autonomic dysfunction.

Key indications include orthostatic hypotension (dizziness upon standing), postural orthostatic tachycardia syndrome (POTS), unexplained syncope, diabetic complication assessment, autonomic involvement in Parkinson's disease or multiple system atrophy, suspected small fiber neuropathy, unexplained sweating abnormalities or bladder dysfunction, complex regional pain syndrome, and autonomic dysfunction. If autonomic symptoms are suspected, please consult a specialist to evaluate the need for testing.

The total testing time varies by institution but is generally about 2 to 3 hours. Adequate recovery time is needed between tests, and pre-test preparation is required for accurate results. Caffeine beverages should be avoided starting the day before, and specific medication instructions from the medical team should be followed on the test day. Most tests can be completed as an outpatient on the same day.

While the autonomic function test battery assesses multiple aspects of autonomic function, it is not infallible. Some early autonomic damage may appear normal on standard testing. In particular, early-stage small fiber neuropathy or regional autonomic abnormalities may require additional specialized tests to detect. Clinical symptoms and test results should be considered together by a specialist.

Heart rate variability (HRV) testing measures subtle variations in heartbeat to primarily assess parasympathetic function and overall autonomic balance. The autonomic function test battery includes HRV testing while adding tilt table testing (orthostatic blood pressure and heart rate response), Valsalva maneuver (heart rate and blood pressure response), and QSART (sudomotor function) for a more comprehensive evaluation of both sympathetic and parasympathetic function. The choice between HRV alone or the full battery depends on symptom complexity.

References

  1. [1] Low PA (1993). "Composite autonomic scoring scale for laboratory quantification of generalized autonomic failure." Mayo Clinic Proceedings, 68: 748-752. DOI PubMed
  2. [2] Freeman R (2006). "Assessment of cardiovascular autonomic function." Clinical Neurophysiology, 117: 716-730. DOI PubMed
  3. [3] Low PA, Opfer-Gehrking TL, Proper CJ, Zimmerman I (1990). "The effect of aging on cardiac autonomic and postganglionic sudomotor function." Muscle & Nerve, 13: 152-157. DOI PubMed
  4. [4] Ewing DJ, Martyn CN, Young RJ, Clarke BF (1985). "The value of cardiovascular autonomic function tests: 10 years experience in diabetes." Diabetes Care, 8: 491-498. DOI PubMed
  5. [5] Sandroni P, Low PA (2009). "Other autonomic neuropathies associated with ganglionic antibody." Autonomic Neuroscience, 146: 13-17. DOI PubMed

Related Articles

Dysautonomia
Autonomic Function Test BatteryAutonomic Function TestingHeart Rate VariabilityTilt Table TestValsalva ManeuverQSART

This content is provided for medical information purposes only and cannot replace professional medical advice. If you have symptoms, please consult a specialist.

Are you concerned about related symptoms?

Get an accurate diagnosis at OSANG Neurosurgery.

02-514-8887 Contact Us